These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 22207323)

  • 1. Mineral and bone disorders and survival in hemodialysis patients with and without polycystic kidney disease.
    Lukowsky LR; Molnar MZ; Zaritsky JJ; Sim JJ; Mucsi I; Kovesdy CP; Kalantar-Zadeh K
    Nephrol Dial Transplant; 2012 Jul; 27(7):2899-907. PubMed ID: 22207323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iron indices and survival in maintenance hemodialysis patients with and without polycystic kidney disease.
    Hatamizadeh P; Ravel V; Lukowsky LR; Molnar MZ; Moradi H; Harley K; Pahl M; Kovesdy CP; Kalantar-Zadeh K
    Nephrol Dial Transplant; 2013 Nov; 28(11):2889-98. PubMed ID: 24169614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of age on survival predictability of bone turnover markers in hemodialysis patients.
    Lertdumrongluk P; Lau WL; Park J; Rhee CM; Kovesdy CP; Kalantar-Zadeh K
    Nephrol Dial Transplant; 2013 Oct; 28(10):2535-45. PubMed ID: 23904397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study.
    Fernández-Martín JL; Martínez-Camblor P; Dionisi MP; Floege J; Ketteler M; London G; Locatelli F; Gorriz JL; Rutkowski B; Ferreira A; Bos WJ; Covic A; Rodríguez-García M; Sánchez JE; Rodríguez-Puyol D; Cannata-Andia JB;
    Nephrol Dial Transplant; 2015 Sep; 30(9):1542-51. PubMed ID: 25920921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of race on hyperparathyroidism, mineral disarrays, administered vitamin D mimetic, and survival in hemodialysis patients.
    Kalantar-Zadeh K; Miller JE; Kovesdy CP; Mehrotra R; Lukowsky LR; Streja E; Ricks J; Jing J; Nissenson AR; Greenland S; Norris KC
    J Bone Miner Res; 2010 Dec; 25(12):2724-34. PubMed ID: 20614473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemoglobin level and survival in hemodialysis patients with polycystic kidney disease and the role of administered erythropoietin.
    Shah A; Molnar MZ; Lukowsky LR; Zaritsky JJ; Kovesdy CP; Kalantar-Zadeh K
    Am J Hematol; 2012 Aug; 87(8):833-6. PubMed ID: 22641426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlates of parathyroid hormone concentration in hemodialysis patients.
    Li J; Molnar MZ; Zaritsky JJ; Sim JJ; Streja E; Kovesdy CP; Salusky I; Kalantar-Zadeh K
    Nephrol Dial Transplant; 2013 Jun; 28(6):1516-25. PubMed ID: 23348879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Kidney and bone update : the 5-year history and future of CKD-MBD. Bone metabolic marker in hemodialysis patients update].
    Okuno S
    Clin Calcium; 2012 Jul; 22(7):1009-17. PubMed ID: 22750933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refining the definition of clinically important mineral and bone disorder in hemodialysis patients.
    Danese MD; Halperin M; Lowe KA; Bradbury BD; Do TP; Block GA
    Nephrol Dial Transplant; 2015 Aug; 30(8):1336-44. PubMed ID: 25817224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Effectiveness of Dialysis Modality on Laboratory Parameters of Mineral Metabolism.
    Soohoo M; Obi Y; Rivara MB; Adams SV; Lau WL; Rhee CM; Kovesdy CP; Kalantar-Zadeh K; Arah OA; Mehrotra R; Streja E
    Am J Nephrol; 2022; 53(2-3):157-168. PubMed ID: 35226895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of pre-kidney transplant markers of mineral and bone disorder with post-transplant outcomes.
    Molnar MZ; Kovesdy CP; Mucsi I; Salusky IB; Kalantar-Zadeh K
    Clin J Am Soc Nephrol; 2012 Nov; 7(11):1859-71. PubMed ID: 22956265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population.
    Floege J; Kim J; Ireland E; Chazot C; Drueke T; de Francisco A; Kronenberg F; Marcelli D; Passlick-Deetjen J; Schernthaner G; Fouqueray B; Wheeler DC;
    Nephrol Dial Transplant; 2011 Jun; 26(6):1948-55. PubMed ID: 20466670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of relatively low serum parathyroid hormone with malnutrition-inflammation complex and survival in maintenance hemodialysis patients.
    Dukkipati R; Kovesdy CP; Colman S; Budoff MJ; Nissenson AR; Sprague SM; Kopple JD; Kalantar-Zadeh K
    J Ren Nutr; 2010 Jul; 20(4):243-54. PubMed ID: 20199875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mineral bone disorder and its management among hemodialysis patients in the Gulf Cooperation Council: Initial findings from the dialysis outcomes and practice patterns study (2012-2015).
    Al Salmi I; AlRukhaimi M; AlSahow A; Shaheen FA; Al-Ghamdi SM; AlAli F; AlGhareeb S; Al Maimani Y; AlGhonaim M; Bieber B; Tentori F; Pisoni RL;
    Saudi J Kidney Dis Transpl; 2016 Nov; 27(6 Suppl 1):62-80. PubMed ID: 27991480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure and survival in long-term hemodialysis patients with and without polycystic kidney disease.
    Molnar MZ; Lukowsky LR; Streja E; Dukkipati R; Jing J; Nissenson AR; Kovesdy CP; Kalantar-Zadeh K
    J Hypertens; 2010 Dec; 28(12):2475-84. PubMed ID: 20720499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detecting high-risk chronic kidney disease-mineral bone disorder phenotypes among patients on dialysis: a historical cohort study.
    Neri L; Kreuzberg U; Bellocchio F; Brancaccio D; Barbieri C; Canaud B; Stuard S; Ketteler M
    Nephrol Dial Transplant; 2019 Apr; 34(4):682-691. PubMed ID: 30165528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Tentori F; Blayney MJ; Albert JM; Gillespie BW; Kerr PG; Bommer J; Young EW; Akizawa T; Akiba T; Pisoni RL; Robinson BM; Port FK
    Am J Kidney Dis; 2008 Sep; 52(3):519-30. PubMed ID: 18514987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.
    Block GA; Klassen PS; Lazarus JM; Ofsthun N; Lowrie EG; Chertow GM
    J Am Soc Nephrol; 2004 Aug; 15(8):2208-18. PubMed ID: 15284307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium, phosphorus, PTH and death rates in a large sample of dialysis patients from Latin America. The CORES Study.
    Naves-Díaz M; Passlick-Deetjen J; Guinsburg A; Marelli C; Fernández-Martín JL; Rodríguez-Puyol D; Cannata-Andía JB
    Nephrol Dial Transplant; 2011 Jun; 26(6):1938-47. PubMed ID: 20513773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different Effects of Iron Indices on Mortality in Patients With Autosomal Dominant Polycystic Kidney Disease After Long-Term Hemodialysis: A Nationwide Population-Based Study.
    Yeh SC; Lin YC; Hong YC; Hsu CC; Lin YC; Wu MS
    J Ren Nutr; 2019 Sep; 29(5):444-453. PubMed ID: 30683605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.